{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["COVID-19", "drug-likeness", "main protease", "molecular docking", "molecular dynamics", "natural-like product"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "32643529", "DateCompleted": {"Year": "2021", "Month": "09", "Day": "08"}, "DateRevised": {"Year": "2021", "Month": "09", "Day": "08"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "07", "Day": "08"}], "Language": ["eng"], "ELocationID": ["10.1080/07391102.2020.1790037"], "Journal": {"ISSN": "1538-0254", "JournalIssue": {"Volume": "39", "Issue": "15", "PubDate": {"Year": "2021", "Month": "Sep"}}, "Title": "Journal of biomolecular structure & dynamics", "ISOAbbreviation": "J Biomol Struct Dyn"}, "ArticleTitle": "Natural-like products as potential SARS-CoV-2 M<sup>pro</sup> inhibitors: <i>in-silico</i> drug discovery.", "Pagination": {"StartPage": "5722", "EndPage": "5734", "MedlinePgn": "5722-5734"}, "Abstract": {"AbstractText": ["In December 2019, a COVID-19 epidemic was discovered in Wuhan, China, and since has disseminated around the world impacting human health for millions. Herein, <i>in-silico</i> drug discovery approaches have been utilized to identify potential natural products (NPs) as Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) main protease (M<sup>pro</sup>) inhibitors. The MolPort database that contains over 100,000 NPs was screened and filtered using molecular docking techniques. Based on calculated docking scores, the top 5,000 NPs/natural-like products (NLPs) were selected and subjected to molecular dynamics (MD) simulations followed by molecular mechanics-generalized Born surface area (MM-GBSA) binding energy calculations. Combined 50\u2009ns MD simulations and MM-GBSA calculations revealed nine potent NLPs with binding affinities (\u0394<i>G<sub>binding</sub></i>) >\u2009-48.0\u2009kcal/mol. Interestingly, among the identified NLPs, four bis([1,3]dioxolo)pyran-5-carboxamide derivatives showed \u0394<i>G<sub>binding</sub></i> >\u2009-56.0\u2009kcal/mol, forming essential short hydrogen bonds with HIS163 and GLY143 amino acids via dioxolane oxygen atoms. Structural and energetic analyses over 50\u2009ns MD simulation demonstrated NLP-M<sup>pro</sup> complex stability. Drug-likeness predictions revealed the prospects of the identified NLPs as potential drug candidates. The findings are expected to provide a novel contribution to the field of COVID-19 drug discovery.Communicated by Ramaswamy H. Sarma."]}, "AuthorList": [{"Identifier": ["0000-0003-4819-2040"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Computational Chemistry Laboratory, Chemistry Department, Faculty of Science, Minia University, Minia, Egypt."}], "LastName": "Ibrahim", "ForeName": "Mahmoud A A", "Initials": "MAA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Computational Chemistry Laboratory, Chemistry Department, Faculty of Science, Minia University, Minia, Egypt."}], "LastName": "Abdeljawaad", "ForeName": "Khlood A A", "Initials": "KAA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Computational Chemistry Laboratory, Chemistry Department, Faculty of Science, Minia University, Minia, Egypt."}], "LastName": "Abdelrahman", "ForeName": "Alaa H M", "Initials": "AHM"}, {"Identifier": ["0000-0002-0343-4969"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chemistry of Medicinal Plants Department, National Research Centre, El-Tahrir St, Dokki, Giza, Egypt."}], "LastName": "Hegazy", "ForeName": "Mohamed-Elamir F", "Initials": "MF"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "J Biomol Struct Dyn", "NlmUniqueID": "8404176", "ISSNLinking": "0739-1102"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Protease Inhibitors"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "COVID-19"}, {"QualifierName": [], "DescriptorName": "Drug Discovery"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Molecular Dynamics Simulation"}, {"QualifierName": [], "DescriptorName": "Protease Inhibitors"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}], "CoiStatement": "No potential conflict of interest was reported by the authors."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Al-Khafaji, K., Al-Duhaidahawi, D., & Taskin Tok, T. (2020). Using integrated computational approaches to identify safe and rapid treatment for SARS-CoV-2. Journal of Biomolecular Structure and Dynamics, 1\u20139. 10.1080/07391102.2020.1764392", "ArticleIdList": ["10.1080/07391102.2020.1764392", "PMC7232881", "32364041"]}, {"Citation": "Bayly, C. I., Cieplak, P., Cornell, W., & Kollman, P. A. (1993). A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges - The RESP model. The Journal of Physical Chemistry, 97(40), 10269\u201310280. 10.1021/j100142a004", "ArticleIdList": ["10.1021/j100142a004"]}, {"Citation": "Berendsen, H. J. C., Postma, J. P. M., van Gunsteren, W. F., DiNola, A., & Haak, J. R. (1984). Molecular-dynamics with coupling to an external bath. The Journal of Chemical Physics, 81(8), 3684\u20133690. 10.1063/1.448118", "ArticleIdList": ["10.1063/1.448118"]}, {"Citation": "Boopathi, S., Poma, A. B., & Kolandaivel, P. (2020). Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment. Journal of Biomolecular Structure and Dynamics, 1\u201310. 10.1080/07391102.2020.1758788", "ArticleIdList": ["10.1080/07391102.2020.1758788", "PMC7196923", "32306836"]}, {"Citation": "Case, D. A., Betz, R. M., Cerutti, D. S., Cheatham, T. E., Darden, T. A., Duke, R. E., Giese, T. J., Gohlke, H., Goetz, A. W., Homeyer, N., Izadi, S., Janowski, P., Kaus, J., Kovalenko, A., Lee, T. S., LeGrand, S., Li, P., Lin, C., Luchko, T., \u2026 Kollman, P. A. (2016). AMBER 2016. University of California."}, {"Citation": "Clark, A. M. (1996). Natural products as a resource for new drugs. Pharmaceutical Research, 13(8), 1133\u20131144. 10.1023/a:1016091631721", "ArticleIdList": ["10.1023/a:1016091631721", "8865302"]}, {"Citation": "Cragg, G. M., Newman, D. J., & Snader, K. M. (1997). Natural products in drug discovery and development. Journal of Natural Products, 60(1), 52\u201360. 10.1021/np9604893", "ArticleIdList": ["10.1021/np9604893", "9014353"]}, {"Citation": "Cucinotta, D., & Vanelli, M. (2020). WHO declares COVID-19: A pandemic. Acta Bio-Medica: Atenei Parmensis, 91(1), 157\u2013160. 10.23750/abm.v91i1.9397", "ArticleIdList": ["10.23750/abm.v91i1.9397", "PMC7569573", "32191675"]}, {"Citation": "Darden, T., York, D., & Pedersen, L. (1993). Particle mesh Ewald: AnN\u22c5log(N) method for Ewald sums in large systems. The Journal of Chemical Physics, 98(12), 10089\u201310092. 10.1063/1.464397", "ArticleIdList": ["10.1063/1.464397"]}, {"Citation": "De Vivo, M., Masetti, M., Bottegoni, G., & Cavalli, A. (2016). Role of molecular dynamics and related methods in drug discovery. Journal of Medicinal Chemistry, 59(9), 4035\u20134061. 10.1021/acs.jmedchem.5b01684", "ArticleIdList": ["10.1021/acs.jmedchem.5b01684", "26807648"]}, {"Citation": "Forli, S., Huey, R., Pique, M. E., Sanner, M. F., Goodsell, D. S., & Olson, A. J. (2016). Computational protein-ligand docking and virtual drug screening with the AutoDock suite. Nature Protocols, 11(5), 905\u2013919. 10.1038/nprot.2016.051", "ArticleIdList": ["10.1038/nprot.2016.051", "PMC4868550", "27077332"]}, {"Citation": "Frisch, M. J., Trucks, G. W., Schlegel, H. B., Scuseria, G. E., Robb, M. A., Cheeseman, J. R., Scalmani, G., Barone, V., Mennucci, B., Petersson, G. A., Nakatsuji, H., Caricato, M., Li, X., Hratchian, H. P., Izmaylov, A. F., Bloino, J., Zheng, G., Sonnenberg, J. L., Hada, M., \u2026 Fox, D. J. (2009). Gaussian 09 (version revision E01). Gaussian Inc."}, {"Citation": "Gasteiger, J., & Marsili, M. (1980). Iterative partial equalization of orbital electronegativity - A rapid access to atomic charges. Tetrahedron, 36(22), 3219\u20133228. 10.1016/0040-4020(80)80168-2", "ArticleIdList": ["10.1016/0040-4020(80)80168-2"]}, {"Citation": "Gentile, D., Patamia, V., Scala, A., Sciortino, M. T., Piperno, A., & Rescifina, A. (2020). Putative inhibitors of SARS-CoV-2 main protease from a library of marine natural products: A virtual screening and molecular modeling study. Marine Drugs, 18(4), 225\u2013233. 10.3390/md18040225", "ArticleIdList": ["10.3390/md18040225", "PMC7231030", "32340389"]}, {"Citation": "Gonzalez-Paz, L., Lossada, C., Moncayo, L., Romero, F., Paz, J., Vera, J., P\u00e9rez, A., San-Blas, E., & Alvarado, Y. (2020). Theoretical molecular docking study of the structural disruption of the viral 3CL-protease of COVID19 induced by binding of capsaicin, piperine and curcumin, part 1: A comparative study with chloroquine and hydrochloroquine two antimalaric drugs. 10.21203/rs.3.rs-21206/v1", "ArticleIdList": ["10.21203/rs.3.rs-21206/v1"]}, {"Citation": "Gordon, J. C., Myers, J. B., Folta, T., Shoja, V., Heath, L. S., & Onufriev, A. (2005). H++: A server for estimating pKas and adding missing hydrogens to macromolecules. Nucleic Acids Research, 33(Web Server issue), W368\u2013W371. 10.1093/nar/gki464", "ArticleIdList": ["10.1093/nar/gki464", "PMC1160225", "15980491"]}, {"Citation": "Harvey, A. L. (2008). Natural products in drug discovery. Drug Discovery Today, 13(19\u201320), 894\u2013901. 10.1016/j.drudis.2008.07.004", "ArticleIdList": ["10.1016/j.drudis.2008.07.004", "18691670"]}, {"Citation": "Hawkins, P. C. D., Skillman, A. G., Warren, G. L., Ellingson, B. A., & Stahl, M. T. (2010). Conformer generation with OMEGA: Algorithm and validation using high quality structures from the Protein Databank and Cambridge Structural Database. Journal of Chemical Information and Modeling, 50(4), 572\u2013584. 10.1021/ci100031x", "ArticleIdList": ["10.1021/ci100031x", "PMC2859685", "20235588"]}, {"Citation": "Heberle, H., Meirelles, G. V., da Silva, F. R., Telles, G. P., & Minghim, R. (2015). InteractiVenn: A web-based tool for the analysis of sets through Venn diagrams. BMC Bioinformatics, 16(1), 169. 10.1186/s12859-015-0611-3", "ArticleIdList": ["10.1186/s12859-015-0611-3", "PMC4455604", "25994840"]}, {"Citation": "Hondermarck, H., Bartlett, N. W., & Nurcombe, V. (2020). The role of growth factor receptors in viral infections: An opportunity for drug repurposing against emerging viral diseases such as COVID-19? FASEB Bioadvances, 2(5), 296\u2013303. 10.1096/fba.2020-00015", "ArticleIdList": ["10.1096/fba.2020-00015", "PMC7211041", "32395702"]}, {"Citation": "Jakalian, A., Jack, D. B., & Bayly, C. I. (2002). Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation. Journal of Computational Chemistry, 23(16), 1623\u20131641. 10.1002/jcc.10128", "ArticleIdList": ["10.1002/jcc.10128", "12395429"]}, {"Citation": "Jin, Z., Du, X., Xu, Y., Deng, Y., Liu, M., Zhao, Y., Zhang, B., Li, X., Zhang, L., Peng, C., Duan, Y., Yu, J., Wang, L., Yang, K., Liu, F., Jiang, R., Yang, X., You, T., Liu, X., \u2026 Yang, H. (2020). Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature, 582(7811), 289\u2013293. 10.1038/s41586-020-2223-y", "ArticleIdList": ["10.1038/s41586-020-2223-y", "32272481"]}, {"Citation": "Kerrigan, J. E. (2013). Molecular dynamics simulations in drug design. In Kortagere S. (Ed.), In silico models for drug discovery (pp. 95\u2013113). Humana Press."}, {"Citation": "Kindrachuk, J., Ork, B., Hart, B. J., Mazur, S., Holbrook, M. R., Frieman, M. B., Traynor, D., Johnson, R. F., Dyall, J., Kuhn, J. H., Olinger, G. G., Hensley, L. E., & Jahrling, P. B. (2015). Antiviral potential of ERK/MAPK and PI3K/AKT/mTOR signaling modulation for middle east respiratory syndrome coronavirus infection as identified by temporal kinome analysis. Antimicrobial Agents and Chemotherapy, 59(2), 1088\u20131099. 10.1128/AAC.03659-14", "ArticleIdList": ["10.1128/AAC.03659-14", "PMC4335870", "25487801"]}, {"Citation": "Kurapati, K. R. V., Atluri, V. S., Samikkannu, T., Garcia, G., & Nair, M. P. N. (2015). Natural products as anti-HIV agents and role in HIV-associated neurocognitive disorders (HAND): A brief overview. Frontiers in Microbiology, 6, 1444\u20131457. 10.3389/fmicb.2015.01444", "ArticleIdList": ["10.3389/fmicb.2015.01444", "PMC4709506", "26793166"]}, {"Citation": "Li, R., Ma, X., Song, Y., Zhang, Y., Xiong, W., Li, L., & Zhou, L. (2019). Anti-colorectal cancer targets of resveratrol and biological molecular mechanism: Analyses of network pharmacology, human and experimental data. Journal of Cellular Biochemistry, 120(7), 11265\u201311273. 10.1002/jcb.28404", "ArticleIdList": ["10.1002/jcb.28404", "30719773"]}, {"Citation": "Liu, C., Zhou, Q., Li, Y., Garner, L. V., Watkins, S. P., Carter, L. J., Smoot, J., Gregg, A. C., Daniels, A. D., Jervey, S., & Albaiu, D. (2020). Research and development on therapeutic agents and vaccines for COVID-19 and related human coronavirus diseases. ACS Central Science, 6(3), 315\u2013331. 10.1021/acscentsci.0c00272", "ArticleIdList": ["10.1021/acscentsci.0c00272", "PMC10467574", "32226821"]}, {"Citation": "Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., Bi, Y., Ma, X., Zhan, F., Wang, L., Hu, T., Zhou, H., Hu, Z., Zhou, W., Zhao, L., \u2026 Tan, W. (2020). Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet (London, England), 395(10224), 565\u2013574. 10.1016/S0140-6736(20)30251-8", "ArticleIdList": ["10.1016/S0140-6736(20)30251-8", "PMC7159086", "32007145"]}, {"Citation": "Maier, J. A., Martinez, C., Kasavajhala, K., Wickstrom, L., Hauser, K. E., & Simmerling, C. (2015). ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB. Journal of Chemical Theory and Computation, 11(8), 3696\u20133713. 10.1021/acs.jctc.5b00255", "ArticleIdList": ["10.1021/acs.jctc.5b00255", "PMC4821407", "26574453"]}, {"Citation": "Mashour, N. H., Lin, G. I., & Frishman, W. H. (1998). Herbal medicine for the treatment of cardiovascular disease: Clinical considerations. Archives of Internal Medicine, 158(20), 2225\u20132234. 10.1001/archinte.158.20.2225", "ArticleIdList": ["10.1001/archinte.158.20.2225", "9818802"]}, {"Citation": "Massova, I., & Kollman, P. A. (2000). Combined molecular mechanical and continuum solvent approach (MM-PBSA/GBSA) to predict ligand binding. Perspectives in Drug Discovery and Design, 18(1), 113\u2013135. 10.1023/A:1008763014207", "ArticleIdList": ["10.1023/A:1008763014207"]}, {"Citation": "Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30(16), 2785\u20132791. 10.1002/jcc.21256", "ArticleIdList": ["10.1002/jcc.21256", "PMC2760638", "19399780"]}, {"Citation": "Mullard, A. (2018). Re-assessing the rule of 5, two decades on. Nature Reviews. Drug Discovery, 17(11), 777. 10.1038/nrd.2018.197", "ArticleIdList": ["10.1038/nrd.2018.197", "30374178"]}, {"Citation": "OMEGA ( Version 2.5.1.4). (2013). Santa Fe, NM: OpenEye Scientific Software."}, {"Citation": "Quinn, R. J., Carroll, A. R., Pham, N. B., Baron, P., Palframan, M. E., Suraweera, L., Pierens, G. K., & Muresan, S. (2008). Developing a drug-like natural product library . Journal of Natural Products, 71(3), 464\u2013468. 10.1021/np070526y", "ArticleIdList": ["10.1021/np070526y", "18257534"]}, {"Citation": "Roux, B., & Simonson, T. (1999). Implicit solvent models. Biophysical Chemistry, 78(1\u20132), 1\u201320. 10.1016/S0301-4622(98)00226-9", "ArticleIdList": ["10.1016/S0301-4622(98)00226-9", "17030302"]}, {"Citation": "Sanders, J. M., Monogue, M. L., Jodlowski, T. Z., & Cutrell, J. B. (2020). Pharmacologic treatments for coronavirus disease 2019 (COVID-19): A review. JAMA, 323(18), 1824\u20131836. 10.1001/jama.2020.6019", "ArticleIdList": ["10.1001/jama.2020.6019", "32282022"]}, {"Citation": "Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003). Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Research, 13(11), 2498\u20132504. 10.1101/gr.1239303", "ArticleIdList": ["10.1101/gr.1239303", "PMC403769", "14597658"]}, {"Citation": "SZYBKI (Version 1.9.0.3). (2016). Santa Fe, NM: OpenEye Scientific Software."}, {"Citation": "Thomas, G. L., & Johannes, C. W. (2011). Natural product-like synthetic libraries. Current Opinion in Chemical Biology, 15(4), 516\u2013522. 10.1016/j.cbpa.2011.05.022", "ArticleIdList": ["10.1016/j.cbpa.2011.05.022", "21684804"]}, {"Citation": "Thorlund, K., Dron, L., Park, J., Hsu, G., Forrest, J. I., & Mills, E. J. (2020). A real-time dashboard of clinical trials for COVID-19.\u00a0The Lancet Digital Health, 2(6), e286\u2013e287.10.1016/S2589-7500(20)30086-8", "ArticleIdList": ["10.1016/S2589-7500(20)30086-8", "PMC7195288", "32363333"]}, {"Citation": "Ul Qamar, T., Alqahtani, S. M., Alamri, M. A., & Chen, L.-L. (2020). Structural basis of SARS-CoV-2 3CL(pro) and anti-COVID-19 drug discovery from medicinal plants. Journal of Pharmaceutical Analysis. 10.1016/j.jpha.2020.03.009", "ArticleIdList": ["10.1016/j.jpha.2020.03.009", "PMC7156227", "32296570"]}, {"Citation": "Wang, J., Wolf, R. M., Caldwell, J. W., Kollman, P. A., & Case, D. A. (2004). Development and testing of a general amber force field. Journal of Computational Chemistry, 25(9), 1157\u20131174. 10.1002/jcc.20035", "ArticleIdList": ["10.1002/jcc.20035", "15116359"]}, {"Citation": "Wells, T. N. (2011). Natural products as starting points for future anti-malarial therapies: Going back to our roots? Malaria Journal, 10 Suppl 1(1), S3. 10.1186/1475-2875-10-S1-S3", "ArticleIdList": ["10.1186/1475-2875-10-S1-S3", "PMC3059461", "21411014"]}, {"Citation": "Zhao, Y. H., Abraham, M. H., Le, J., Hersey, A., Luscombe, C. N., Beck, G., Sherborne, B., & Cooper, I. (2002). Rate-limited steps of human oral absorption and QSAR studies. Pharmaceutical Research, 19(10), 1446\u20131457. 10.1023/A:1020444330011", "ArticleIdList": ["10.1023/A:1020444330011", "12425461"]}, {"Citation": "Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., Niu, P., Zhan, F., Ma, X., Wang, D., Xu, W., Wu, G., Gao, G. F., Tan, W., & China Novel Coronavirus Investigating and Research Team. (2020). A Novel Coronavirus from patients with pneumonia in China, 2019 . New England Journal of Medicine, 382(8), 727\u2013733. 10.1056/NEJMoa2001017", "ArticleIdList": ["10.1056/NEJMoa2001017", "PMC7092803", "31978945"]}]}], "History": [{"Year": "2020", "Month": "7", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "9", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "7", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "8", "Day": "24"}], "PublicationStatus": "ppublish", "ArticleIdList": ["32643529", "PMC7443551", "10.1080/07391102.2020.1790037"]}}]}